UC DIS.CERT. 06/24 D2G/ DE000HC5L3R5 /
17.05.2024 13:46:07 | Изменение- | Бид15:08:44 | Предложение17.05.2024 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
54.000EUR | - | 54.250 Величина цены спроса: 2,000 |
- Величина цены предложения: 2,000 |
ORSTED A/S ... | - - | 28.06.2024 | Call |
GlobeNewswire
13:03
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor...
GlobeNewswire
13:00
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
13:00
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
GlobeNewswire
13:00
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
GlobeNewswire
13:00
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offer...
GlobeNewswire
13:00
Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nomin...
GlobeNewswire
13:00
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA...
GlobeNewswire
13:00
Pyro Green-Gas Signs Contracts Totaling $1.3 Million with Global Steel Company to Desulphurize Coke ...
GlobeNewswire
13:00
Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
GlobeNewswire
13:00
Sandy Spring Bancorp’s Board of Directors Appoints Charles S. Cullum Chief Financial Officer
GlobeNewswire
13:00
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
13:00
Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spec...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница